Cowen analyst Ritu Baral raised the price target on Krystal Biotech (NASDAQ: KRYS) to $111.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Krystal Biotech (KRYS) Prices 2.67M Share Offering at $75/shDecember 1, 2021 5:25 AM Krystal Biotech (KRYS) Announces Proposed $200M Stock OfferingNovember 29, 2021 4:20 PM Krystal Biotech (KRYS) call put ratio 1 call to 2.9 puts as shares rally 119% after data releaseNovember 29, 2021 11:27 AM Increasing unusual call option volume: CBRE HTA MPLN CNDT NUAN KRYSNovember 29, 2021 11:19 AM Increasing unusual option volume: HTA KRYS CARS EWG NRXPNovember 29, 2021 9:56 AM Pre-Open Stock Movers 11/29: (KRYS) (ADGI) (TWTR) Higher; (MRK) (UPS) Lower (more...)November 29, 2021 9:30 AM Krystal Biotech (KRYS) Surges 125% Following Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK in Patients with Dystrophic Epidermolysis BullosaNovember 29, 2021 7:11 AM Krystal Biotech (KRYS) Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK in Patients with Dystrophic Epidermolysis BullosaNovember 29, 2021 7:05 AM Krystal Biotech Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK™ in Patients with Dystrophic Epidermolysis BullosaNovember 29, 2021 7:00 AM